메뉴 건너뛰기




Volumn 7, Issue 3, 2007, Pages 335-343

Radionuclide therapy of cancer with radiolabeled antibodies

Author keywords

Carcinoembryonic antigen; CD20; Colorectal cancer; G250; Monoclonal antibodies; Non Hodgkin's lymphoma; Radioimmunotherapy; Radionuclide; Renal cell cancer

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 2 (4 AMINOBENZYL)PENTETIC ACID; ANTINEOPLASTIC AGENT; COPPER 67; EPRATUZUMAB RE 186; EPRATUZUMAB TC 99M; EPRATUZUMAB Y 90; HUMANIZED MONOCLONAL ANTIBODY MN 14 I 131; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN F(AB')2 FRAGMENT I 131; IODINE 125; IODINE 131; ISOTHIOCYANATOBENZYL PENTETIC ACID; LUTETIUM 177; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CT84.66 Y 90; MONOCLONAL ANTIBODY NP 4 I 131; MONOCLONAL ANTIBODY PENTETIC ACID; MONOCLONAL ANTIBODY Y 90; RADIOIODINATED MONOCLONAL ANTIBODY; RADIOIODINATED TYROSINE; RADIOISOTOPE; RHENIUM 186; RHENIUM 188; RITUXIMAB; TOSITUMOMAB; TOSITUMOMAB I 131; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG; YTTRIUM 90;

EID: 34249278467     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152007780618126     Document Type: Review
Times cited : (26)

References (95)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.